Evidence map›Paper›PMID 42101954›Full record

ArticleJournal of natural products2026

Genome Mining-Guided Discovery of the Glycosylated Griseorhodin Congener Ruskamycin.

Sven T Sowa, Heiner G Weddeling, Robin Teufel

Abstract read
In one paragraph

Article in Journal of natural products, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sven T SowaPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Heiner G WeddelingPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Robin TeufelPharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.ORCID 0000-0001-5863-7248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatic polyketides from Actinobacteria are a class of natural products with potential for clinical application due to their antibiotic and cytotoxic activities. Among the most complex members are the closely related rubromycins and griseorhodins, which are derived from a pentangular backbone that undergoes extensive oxidative tailoring to afford a characteristic bisbenzannulated spiroketal pharmacophore. Recent insights into the characteristic genetics and enzymology underlying the biosynthesis of these polyketides now enable the bioinformatics-driven search for further congeners. Here, we analyzed 154 available and manually selected rubromycin/griseorhodin biosynthetic gene clusters (BGCs) with the help of the tool BisCEET, which allowed the rapid identification and visualization of "variant-specific tailoring genes" (VSTGs), encoding putative tailoring enzymes required only for individual congeners. This approach revealed a striking BGC variant in the genome of the Actinomycete

Indexed as

ActinobacteriaAnti-Bacterial AgentsGlycosylationMolecular StructureMultigene FamilyPolyketidesSpiro CompoundsAnti-Bacterial AgentsPolyketidesSpiro Compounds

Identifiers

PMID42101954
PMCPMC13200261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.